日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dengue and chikungunya among outpatients with acute undifferentiated fever in Kinshasa, Democratic Republic of Congo: A cross-sectional study

刚果民主共和国金沙萨急性不明原因发热门诊患者中登革热和基孔肯雅热的横断面研究

期刊:PLoS Neglected Tropical Diseases
影响因子:3.4
doi:10.1371/journal.pntd.0007047
Proesmans, Sam; Katshongo, Freddy; Milambu, John; Fungula, Blaise; Muhindo Mavoko, Hypolite; Ahuka-Mundeke, Steve; Inocêncio da Luz, Raquel; Van Esbroeck, Marjan; Ariën, Kevin K; Cnops, Lieselotte; De Smet, Birgit; Lutumba, Pascal; Van Geertruyden, Jean-Pierre; Vanlerberghe, Veerle
微生物学
登革热
发表日期：2019
文献求助 收藏

Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo

在刚果民主共和国金沙萨，评估青蒿琥酯-阿莫地喹、蒿甲醚-苯芴醇和奎宁联合克林霉素治疗单纯性恶性疟疾的安全性和耐受性。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0222379
Lula Ntamba, Yves; Muhindo Mavoko, Hypolite; Kalabuanga, Marion; Fungula, Blaise; Ntamabyaliro Nsengi, Pierre-Michel; Tona Lutete, Gaston; Inocencio da Luz, Raquel; Van Geertruyden, Jean-Pierre; Lutumba, Pascal
微生物学
疟疾
发表日期：2019
文献求助 收藏

Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies

帕呋拉米定（一种用于治疗第一阶段昏睡病的新型口服药物）在 2a 期临床研究和 2b 期随机临床研究中的疗效、安全性和剂量

期刊:PLoS Neglected Tropical Diseases
影响因子:3.4
doi:10.1371/journal.pntd.0004362
Burri, Christian; Yeramian, Patrick D; Allen, James L; Merolle, Ada; Serge, Kazadi Kyanza; Mpanya, Alain; Lutumba, Pascal; Mesu, Victor Kande Betu Ku; Bilenge, Constantin Miaka Mia; Lubaki, Jean-Pierre Fina; Mpoto, Alfred Mpoo; Thompson, Mark; Munungu, Blaise Fungula; Manuel, Francisco; Josenando, Théophilo; Bernhard, Sonja C; Olson, Carol A; Blum, Johannes; Tidwell, Richard R; Pohlig, Gabriele
发表日期：2016
文献求助 收藏

Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial

帕呋拉米定与马来酸喷他脒治疗第一阶段昏睡病的疗效和安全性：一项随机、对照、国际3期临床试验

期刊:PLoS Neglected Tropical Diseases
影响因子:3.4
doi:10.1371/journal.pntd.0004363
Pohlig, Gabriele; Bernhard, Sonja C; Blum, Johannes; Burri, Christian; Mpanya, Alain; Lubaki, Jean-Pierre Fina; Mpoto, Alfred Mpoo; Munungu, Blaise Fungula; N'tombe, Patrick Mangoni; Deo, Gratias Kambau Manesa; Mutantu, Pierre Nsele; Kuikumbi, Florent Mbo; Mintwo, Alain Fukinsia; Munungi, Augustin Kayeye; Dala, Amadeu; Macharia, Stephen; Bilenge, Constantin Miaka Mia; Mesu, Victor Kande Betu Ku; Franco, Jose Ramon; Dituvanga, Ndinga Dieyi; Tidwell, Richard R; Olson, Carol A
发表日期：2016
文献求助 收藏